Esphera SynBio
Esphera SynBio is a synthetic biology company specializing in the development of nanomedicine vaccines for cancer and infectious diseases. Utilizing a breakthrough platform of proprietary transgenes, the company produces engineered exosomes in vivo, which serve as innovative therapeutic solutions in the field of vaccine development.
Leadership & Board
- Current Number of Employees
- 10
- Current LinkedIn Followers
- 711
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $2M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $2M
- Latest Funding Round
- Seed Round
- Post-Money Valuation
- ―
Employee Trend
Esphera SynBio had 10 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
10Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Esphera SynBio had 711 followers as of October 12, 2026. The number of followers increased by 3 (0.42%) week-over-week.
711Latest Followers Count
3(0.42%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 07, 2025 | Seed Round | $2.00M | ― |
Similar Companies
A snapshot of private companies similar to Esphera SynBio, helping you discover and navigate related company profiles.
